Trial intelligence / Profile preview

Remifentanil vs Propofol for ICU Sedation

NCT00436345Phase 3Terminated

Sponsor
GSK
Start
Nov 2007
Primary completion
Aug 2008
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of remifentanil in pain, sponsored by GSK. Started Nov 2007; status: terminated.

02

Drugs

remifentanil
03

Conditions

pain

Beyond the preview

Go deeper on NCT00436345.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00436345.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call